Big Market Research “Autoimmune Diseases Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/autoimmune-diseases-in-the-us-2015-2019-market Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents.
Big Market Research “Global Inflammatory Bowel Disease Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast. Visit for more info @ http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss.
The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management. The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors. Analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-inflammatory-bowel-disease-2015-2019-market
SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of flare-ups and remissions and can range from mild to life threatening in severity. No cure for SLE yet exists. Read more details at: http://www.bigmarketresearch.com/global-systemic-lupus-erythematosus-sle-drugs-2015-2019-market
Big Market Research has announced a new report “Immunoprotein Diagnostic Testing Market- Size, Share, Trends, Forecast 2020” Enquire about this report @ http://www.bigmarketresearch.com/purchase-enquiry/371478 Growing focus on early disease diagnosis is the key driver for the growth of this market. Early diagnosis by immunoprotein diagnostic devices helps in disease screening and patient care management during a disease outbreak. Get Complete Report @ http://www.bigmarketresearch.com/global-immunoprotein-diagnostic-testing-market
Omega-3 fatty acids are polyunsaturated fatty acids, found in foods such as fish, vegetable oil, flaxseeds and others that are important for the functions of the body.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Autoimmune Disease Diagnostics Consumption market analysis is provided for the international market including development history, competitive landscape analysis, and major regions? development status.
Get more details @ http://bit.ly/2eg7VII Global autoimmune disease diagnostics market share is undergoing rapid consolidation, and is marked by the presence of extensive mergers and acquisitions. Major players compete on the basis of price, and introduction of new technologically improved diagnostic kits in the market.
Bharat Book Bureau provides the report, on “ Diagnostics industry analysis Global Immunoprotein Diagnostic Testing Market 2015-2019” This Report market research analyst has estimated the infectious disease testing segment to be the largest market segment during the forecast period. https://www.bharatbook.com/diagnostics-market-research-reports-739734/global-immunoprotein-diagnostic-testing.html
Get more details @ http://bit.ly/2koLbde Global autoimmune disease diagnostics market share is undergoing rapid consolidation, and is marked by the presence of extensive mergers and acquisitions. Siemens Healthcare, Abbott Laboratories, Roche Diagnostics, and Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, Euroimmun, INOVA Diagnostics, Inc. are major industry participants.
Big Market Research “Protein Engineering Market by Technology” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.prnewswire.com/news-releases/protein-engineering-market-would-grow-at-157--cagr-amid-the-period-2015-2020-521544791.html Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design) , Product (Instrument, Services) , Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone) Global Forecast to 2020 - Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions.
Get more details @ http://bit.ly/2koLbde Global autoimmune disease diagnostics market share is undergoing rapid consolidation, and is marked by the presence of extensive mergers and acquisitions. Siemens Healthcare, Abbott Laboratories, Roche Diagnostics, and Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, Euroimmun, INOVA Diagnostics, Inc. are major industry participants.
The global autoinjector market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The market is driven by the factorssuch as high prevalence of chronic and lifestyle associated diseases, increasing number of regulatory approvals, technology anddesign improvement, escalating patient attentiveness and inclination of patients regarding self-administration. The prefilled autoinjectors are the major contributor to the global market., as more patients preferred disposable injectors due to ease of their usage and lower chances of any contamination.
The report on Biosimilar Monoclonal Antibodies by Infinium Global Research analyzes the the Biosimilar Monoclonal Antibodies Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Biosimilar Monoclonal Antibodies Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global markets of Biosimilar Monoclonal Antibodies.
The report on Autoimmune Disease Diagnostics Market by type(localized autoimmune disease diagnostics and systemic autoimmune disease diagnostics) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Autoimmune Disease Diagnostics Market is projected to grow at a CAGR of 3.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Get more details at: http://www.apacmarket.com/top-market/anti-inflammatory-therapeutics-market
Technavios market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market.
Research Beam added a report on “Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015” Enquiry about report: http://www.researchbeam.com/auto-immune-diseases-medical-devices-pipeline-assessment-2015-market/enquire-about-report
Big Market Research “Regenerative Medicine Market 2022” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast
SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. Read more details at: http://www.bigmarketresearch.com/global-systemic-lupus-erythematosus-sle-drugs-2015-2019-market
Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms.
In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. To know more visit us @ http://www.apacmarket.com/top-market/apac-in-vitro-diagnostics-market
Big Market Research, Indian Coronary Stent Market Size, Share, Forecast, Trends, Growth, Demand, Analysis, Research, Report, Insights, Outlook to 2019.Heart diseases are on the rise in India. It is estimated that 10 percent of urban adult population and 5 percent of rural adult population suffer from some form of heart diseases and 20-30 percent of them require specialized investigation and treatment to prevent deaths due to heart ailments and coronary vascular diseases (CVD). market research report titled “Indian Coronary Stent Market Forecast to 2019”. The new research report revealed vivid and elaborate market information. For the decision makers of the coronary stents manufacturing companies this report, no doubt, will be a helpful tool to get the clear picture of the Indian market.
The global biosimilars market size was valued at 3.39 billion in 2016 and is expected to grow on account of increasing prevalence of chronic diseases such as cancer and autoimmune disorders. Additionally, increasing prevalence of arthritic disorder and obesity across the globe in geriatric population is anticipated to drive the demand for biosimilar over the study period.
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands and feet, which hinders patient mobility. Without treatment, the disease leads to joint destruction and disability. Prior to 1998, treatment options were limited to small-molecule disease-modifying therapies, such as Methotrexate (MTX), sulfasalazine and anti-malarials. However, while MTX is efficacious in controlling RA symptoms in a large percentage of patients, approximately 33% are unresponsive to these first-line drugs. Read more details at: http://www.bigmarketresearch.com/rheumatoid-arthritis-to-2020-a-crowded-characterized-by-modest-growth-market
The report offers an in-depth analysis of the “Global Rheumatoid Arthritis Market” segmented into global and regional market. For more mail: vikas@konceptanalytics.com
Adroit Market Research, recently published a detailed market research study focused on the “Biosimilars Market” across the global, regional and country level.
The report covers the analysis of global as well as regional markets of Gluten Free Food. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
Anatomic Pathology Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2015-2022 The Global anatomic pathology market is expected to grow at a CAGR of 6.8 % during 2017-2022. The branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically is known as Anatomic (or anatomical) pathology.
According to #TechSci Research report, Surgical Gloves Market stood at USD3274.28 million in 2021 and expected to grow at CAGR by 2027 on account of factors like increasing instances of chronic diseases. Gain More Insight: https://bit.ly/3B73JTt Get Sample Report: https://bit.ly/3GA6xK9 Press Release: https://bit.ly/3B73JTt Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024
Antibody Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD).
North America Injectable Drug Delivery Market – By Type {Devices (Conventional, Self), Formulations (Conventional, Noble, Long Acting)} Applications (Autoimmune Diseases, Hormonal Disorders, Others) Usage Pattern (Curative Care, Immunizations, Other Usage Patterns) Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies) Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
The report on Biosimilar Monoclonal Antibodies Market by drug class (rituximab, infliximab, abciximab, trastuzumab, adalimumab, bevacizumab), application (oncology, chronic, auto immune diseases, growth hormone deficiency, infectious diseases) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Biosimilar Monoclonal Antibodies Market is projected to grow at a CAGR of 42.8% in terms of value over the period of 2017-2023.
Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024
Auto-Immune Diseases Medical Devices Pipeline Assessment, 2015 provides an overview of Auto-Immune Diseases currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.
According to The Business Research Company, Demand for Filgrastim Biosimilars Market has witnessed a growth trajectory over the past few years & it focuses on several aspects of a business process. https://bit.ly/2FRc0mF
Breakthrough Therapy (BT) Designation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breakthrough Therapy (BT) Designation market will be able to gain the upper hand as they use the report as a powerful resource.
The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020.
The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020.
Biosimilars/follow-on-biologics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/follow-on-biologics market will be able to gain the upper hand as they use the report as a powerful resource.
Middle-East & Africa Monoclonal Antibodies Market is estimated to be USD 2.16 Billion in 2015 and is expected to reach USD 4 Billion by 2020 with a growth rate of 13%.
North America Monoclonal Antibodies Market is estimated to be a USD 10.26 billion market in 2015 and is expected to reach USD 17 billion market by the end of 2020 with a significant growth rate of 10.5%.
The North America healthcare IT outsourcing market is expected to grow at a CAGR of 8.9% from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.